Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evaluating CBT-004 ophthalmic solution in patients with vascularized pinguecula and associated conjunctival hyperemia. Key Phase 2 Results Primary Endpoint Achieved: Both investigated concentrations of CBT-004 demonstrated statistically significant improvements in conjunctival hyperemia compared to...

One year after announcing its vision to phase out manual card entry and drive 100% tokenisation, Mastercard is celebrating major strides across Europe, where a growing number of partners are adopting the technologies that underpin safer, smarter digital commerce. Nearly half of Mastercard e-commerce transactions are now tokenised in Europe. These tokenised transactions, including Secure Card on File (SCOF), Click to Pay, and digital wallets, have increased by ove...